Showing results (11-20 of 326) with videos related to
Sort By:
Pageof 33
European Journal of Cancer (Oxford, England : 1990)|January 3, 2024
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role?Anna Maria Di Giacomo, Michael Lahn, Alexander Mm Eggermont, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 29, 2018
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3<sup>+</sup> Regulatory T Cells (Tregs) in Human CancersAnu Sharma, Sumit K Subudhi, Jorge Blando, et al.Nature Communications|February 15, 2017
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunityDmitriy Zamarin, Rikke B Holmgaard, Jacob Ricca, et al.Journal of Clinical Immunology|November 4, 2011
Current and emerging treatment options for castration-resistant prostate cancer: a focus on immunotherapyWinald R Gerritsen, Padmanee SharmaExpert Review of Vaccines|December 22, 2009
Mechanisms of T-cell inhibition: implications for cancer immunotherapyElizabeth A Mittendorf, Padmanee SharmaCancer Immunology Research|July 11, 2019
Immunologic Correlates of Pathologic Complete Response to Preoperative Immunotherapy in Hepatocellular CarcinomaAhmed Omar Kaseb, Luis Vence, Jorge Blando, et al.Nature Reviews. Immunology|July 2, 2026
A guide to CAR T cell therapies: development, current status and future prospectsHind Rafei, Ranjan Upadhyay, Padmanee SharmaCancer Research|June 29, 2011
The ICOS/ICOSL pathway is required for optimal antitumor responses mediated by anti-CTLA-4 therapyTihui Fu, Qiuming He, Padmanee SharmaJournal for Immunotherapy of Cancer|March 19, 2025
ICOS-expressing CAR-T cells mediate durable eradication of triple-negative breast cancer and metastasisShelley Herbrich, Mehdi Chaib, Padmanee SharmaPageof 33